Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Radiopharm Theranostics - Dual Action Antibody Investor Deck (ASX:RAD)

To view the presentation, download the attached PDF.

Radiopharm Theranostics - LOI with GenesisCare to start first trial in Australia (ASX:RAD)

Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses...read more

Radiopharm Theranostics - Meet CEO Riccardo Canevari (ASX:RAD)

Greetings to our shareholders and all reading this... I’m looking forward to my first face to face meetings with many of you in Australia as part of an upcoming roadshow for RAD. These past...read more

Radiopharm Theranostics - Half Yearly Report and Accounts (ASX:RAD)

To view the report, download the attached PDF.

Radiopharm Theranostics - Radiopharm and Terrapower supplementary announcement (ASX:RAD)

SYDNEY, Australia February 10, 2022 – Further to the announcement of the supply agreement with TerraPower released on 1 February 2022, at the request of the ASX, Radiopharm Theranostics (ASX: ...read more

Radiopharm Theranostics - Initial Director's Interest Notice - HL (ASX:RAD)

To view the Initial Director’s Interest Notice, download the attached PDF.

Radiopharm Theranostics - Hester Larkin appointed as Non-Executive Director (ASX:RAD)

Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic us...read more

Radiopharm Theranostics - Director Appointment/Resignation (ASX:RAD)

Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic us...read more

Radiopharm Theranostics - Radiopharm and TerraPower sign Actinium 225 agreement (ASX:RAD)

SYDNEY, Australia and BELLEVUE, Washington – January 31st, 2022 - Radiopharm Theranostics (ASX: RAD) and TerraPower, a leading nuclear innovation company, today announced an agreement that wil...read more

Radiopharm Theranostics - Application for quotation of securities - RAD (ASX:RAD)

To view the Application for quotation of +securities, download the attached PDF.

Radiopharm Theranostics - Quarterly Activities/Appendix 4C Cash Flow Report (ASX:RAD)

To view the report, download the attached PDF.

Radiopharm Theranostics - Proposed issue of securities - RAD (ASX:RAD)

To view the Proposed issue of securities, download the attached PDF.

Radiopharm Theranostics - RAD acquires IP Ownership of Radiopharmaceutical Nanobodies (ASX:RAD)

-- Promising therapeutic applications in addition to imaging -- Allows RAD unfettered global rights to partner or sub-license & secures direct ownership chain to patents -- Targeting highly re...read more

Radiopharm Theranostics - Change of Director's Interest Notice - RC (ASX:RAD)

To view the Change of Director’s Interest Notice, download the attached PDF.

Radiopharm Theranostics - RAD to present at Biotech Showcase (ASX:RAD)

Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic us...read more

Viewing: 61 - 75 of 104 Previous | Next